Atopic Dermatitis Drugs Market – Global Industry Analysis and Forecast (2022-2029)

Atopic Dermatitis Drugs Market was valued at US$ 4.15 Bn in 2021 and is expected to reach US$ 5.92 Bn by 2029, at a CAGR of 4.54% during a forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Global Atopic Dermatitis Drugs Market To know about the Research Methodology :- Request Free Sample Report

Atopic Dermatitis Drugs Market Dynamics

Atopic dermatitis is a medical disorder, which often seems like a red, itchy, rash normally on the cheeks, arms, and legs. It's generally seen in early childhood and is more common in people who have a family history of this disorder. Atopic dermatitis is chronic & tends to flare periodically, and it may be accompanied by asthma & heavy fever. Treatment for atopic dermatitis is avoiding soap & other irritants and certain creams & ointments may also provide relief from the itching as well rashes. The rising occurrence of food allergies exacerbating atopic dermatitis, increasing focus on systematic therapies, and the growing use of pharmacological products in developing countries are boosting the growth of the atopic dermatitis drugs market. Major limiting factors of the global atopic dermatitis drug market are side effects, the high cost of treatment, and a lack of good & safe therapeutics.

Atopic Dermatitis Drugs Segment Analysis

The topical route of the administration segment is accounted for the largest market share and leads the market during the forecast period owing to the most effective treatment with the least side effects, high patience adherence, cost-effectiveness, and less pain. A topical medication is applied to body surfaces such as the skin and mucous membranes to treat ailments through a large range of classes including creams, foams, gels, lotions, and ointments. An oral segment is the most frequently used route of drug administration and is the most appropriate and cost-effective. Although solid-dose forms like tablets & capsules have a high degree of drug stability & provide accurate dosage, the oral route is problematic due to the unpredictable nature of gastrointestinal absorption.

Atopic Dermatitis Drugs Market Regional Insights

North America is expected to hold the largest share during the forecast period owing to the growing cases of atopic dermatitis in children is the rising prevalence of food & skin allergies. Furthermore, new product launch in the US is also expected to generate large revenue and drive market growth in the region. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

Atopic Dermatitis Drugs Market, Key Highlights

• Global Atopic Dermatitis Drugs Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Global Atopic Dermatitis Drugs Market • Global Atopic Dermatitis Drugs Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Atopic Dermatitis Drugs Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Atopic Dermatitis Drugs Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning, and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion, and competitive landscape of the key players operating in the Global Atopic Dermatitis Drugs Market are also profiled.

The Scope of the Global Atopic Dermatitis Drugs Market

Global Atopic Dermatitis Drugs Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 4.15 Bn.
Forecast Period 2022 to 2029 CAGR: 4.54% Market Size in 2029: US $ 5.92 Bn.
Segments Covered: by Therapy • Photo Therapy • Directed Therapy
by Route of Administration • Injectable • Oral • Topical
by End User • Hospitals • Clinics • Research Labs

Atopic Dermatitis Drugs Market, by Region

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Atopic Dermatitis Drugs Market Key Players

Mylan • LEO Pharma • Bayer HealthCare • Encore Dermatology • Novartis AG • Valent Pharmaceutical Inc. • Astellas Pharma Inc. • Meda AB • Valeant • Bayer Ag • Astellas Pharma Inc • Ancor Pharmaceutical • Regenron Pharmaceutical • Allergan • Pfizer Inc Frequently Asked Questions: 1. Which region has the largest share in Global Atopic Dermatitis Drugs Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Atopic Dermatitis Drugs Market? Ans: The Global Atopic Dermatitis Drugs Market is growing at a CAGR of 4.54% during forecasting period 2022-2029. 3. What is scope of the Global Atopic Dermatitis Drugs Market report? Ans: Global Atopic Dermatitis Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Atopic Dermatitis Drugs Market is studied from 2021 to 2029.

Global atopic dermatitis drugs market

1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Atopic Dermatitis Drugs Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7Key Trends in Global Atopic Dermatitis Drugs Market 5. Global Atopic Dermatitis Drugs Market Analysis and Forecast 5.1. Global Atopic Dermatitis Drugs Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By Therapy 6.1. Introduction and Definition 6.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 6.3. Global Atopic Dermatitis Drugs Market Size (US$ Bn) Forecast, By Therapy 6.4. Global Atopic Dermatitis Drugs Market Analysis, By Therapy 6.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By Therapy 6.6. Key Trends 6.6.1. Key Developments 7. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By Route of Administration 7.1. Introduction and Definition 7.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 7.3. Global Atopic Dermatitis Drugs Market Size (US$ Bn) Forecast, By Route of Administration 7.4. Global Atopic Dermatitis Drugs Market Analysis, By Route of Administration 7.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By Route of Administration 7.6. Key Trends 7.6.1. Key Developments 8. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By End User 8.3. Global Atopic Dermatitis Drugs Market Size (US$ Bn) Forecast, By End User 8.4. Global Atopic Dermatitis Drugs Market Analysis, By End User 8.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By End User 8.6. Key Trends 8.6.1. Key Developments 9. Global Atopic Dermatitis Drugs Market Analysis, by Region 9.1. Global Atopic Dermatitis Drugs Market Value Share Analysis, by Region 9.2. Global Atopic Dermatitis Drugs Market Size (US$ Bn) Forecast, by Region 9.3. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, by Region 9.4. Key Trends 9.4.1. Key Developments 10. North America Atopic Dermatitis Drugs Market Analysis 10.1. North America Atopic Dermatitis Drugs Market Overview 10.2. North America Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 10.3. North America Atopic Dermatitis Drugs Market Forecast, By Therapy 10.3.1. Photo Therapy 10.3.2. Directed Therapy 10.4. North America Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 10.5. North America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.5.1. Injectable 10.5.2. Oral 10.5.3. Topical 10.6. North America Atopic Dermatitis Drugs Market Value Share Analysis, By End User 10.7. North America Atopic Dermatitis Drugs Market Forecast, By End User 10.7.1. Hospitals 10.7.2. Clinics 10.7.3. Research Labs 10.8. North America Atopic Dermatitis Drugs Market Value Share Analysis, by Country 10.9. North America Atopic Dermatitis Drugs Market Forecast, by Country 10.9.1. U.S. 10.9.2. Canada 10.10. North America Atopic Dermatitis Drugs Market Analysis, by Country 10.11. U.S. Atopic Dermatitis Drugs Market Forecast, By Therapy 10.11.1. Photo Therapy 10.11.2. Directed Therapy 10.12. U.S. Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.12.1. Injectable 10.12.2. Oral 10.12.3. Topical 10.13. U.S. Atopic Dermatitis Drugs Market Forecast, By End User 10.13.1. Hospitals 10.13.2. Clinics 10.13.3. Research Labs 10.14. Canada Atopic Dermatitis Drugs Market Forecast, By Therapy 10.14.1. Photo Therapy 10.14.2. Directed Therapy 10.15. Canada Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.15.1. Injectable 10.15.2. Oral 10.15.3. Topical 10.16. Canada Atopic Dermatitis Drugs Market Forecast, By End User 10.16.1. Hospitals 10.16.2. Clinics 10.16.3. Research Labs 10.17. North America Atopic Dermatitis Drugs Market Attractiveness Analysis 10.17.1. By Therapy 10.17.2. By Route of Administration 10.17.3. By End User 10.18. PEST Analysis 10.19. Key Trends 10.19.1. Key Developments 11. Europe Atopic Dermatitis Drugs Market Analysis 11.1. Europe Atopic Dermatitis Drugs Market Overview 11.2. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 11.3. Europe Atopic Dermatitis Drugs Market Forecast, By Therapy 11.3.1. Photo Therapy 11.3.2. Directed Therapy 11.4. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 11.5. Europe Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.5.1. Injectable 11.5.2. Oral 11.5.3. Topical 11.6. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By End User 11.7. Europe Atopic Dermatitis Drugs Market Forecast, By End User 11.7.1. Hospitals 11.7.2. Clinics 11.7.3. Research Labs 11.8. Europe Atopic Dermatitis Drugs Market Value Share Analysis, by Country 11.9. Europe Atopic Dermatitis Drugs Market Forecast, by Country 11.9.1. Germany 11.9.2. U.K. 11.9.3. France 11.9.4. Italy 11.9.5. Spain 11.9.6. Rest of Europe 11.10. Europe Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 11.11. Germany Atopic Dermatitis Drugs Market Forecast, By Therapy 11.11.1. Photo Therapy 11.11.2. Directed Therapy 11.12. Germany Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.12.1. Injectable 11.12.2. Oral 11.12.3. Topical 11.13. Germany Atopic Dermatitis Drugs Market Forecast, By End User 11.13.1. Hospitals 11.13.2. Clinics 11.13.3. Research Labs 11.14. U.K. Atopic Dermatitis Drugs Market Forecast, By Therapy 11.14.1. Photo Therapy 11.14.2. Directed Therapy 11.15. U.K. Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.15.1. Injectable 11.15.2. Oral 11.15.3. Topical 11.16. U.K. Atopic Dermatitis Drugs Market Forecast, By End User 11.16.1. Hospitals 11.16.2. Clinics 11.16.3. Research Labs 11.17. France Atopic Dermatitis Drugs Market Forecast, By Therapy 11.17.1. Photo Therapy 11.17.2. Directed Therapy 11.18. France Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.18.1. Injectable 11.18.2. Oral 11.18.3. Topical 11.19. France Atopic Dermatitis Drugs Market Forecast, By End User 11.19.1. Hospitals 11.19.2. Clinics 11.19.3. Research Labs 11.20. Italy Atopic Dermatitis Drugs Market Forecast, By Therapy 11.20.1. Photo Therapy 11.20.2. Directed Therapy 11.21. Italy Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.21.1. Injectable 11.21.2. Oral 11.21.3. Topical 11.22. Italy Atopic Dermatitis Drugs Market Forecast, By End User 11.22.1. Hospitals 11.22.2. Clinics 11.22.3. Research Labs 11.23. Spain Atopic Dermatitis Drugs Market Forecast, By Therapy 11.23.1. Photo Therapy 11.23.2. Directed Therapy 11.24. Spain Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.24.1. Injectable 11.24.2. Oral 11.24.3. Topical 11.25. Spain Atopic Dermatitis Drugs Market Forecast, By End User 11.25.1. Hospitals 11.25.2. Clinics 11.25.3. Research Labs 11.26. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By Therapy 11.26.1. Photo Therapy 11.26.2. Directed Therapy 11.27. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.27.1. Injectable 11.27.2. Oral 11.27.3. Topical 11.28. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By End User 11.28.1. Hospitals 11.28.2. Clinics 11.28.3. Research Labs 11.29. Europe Atopic Dermatitis Drugs Market Attractiveness Analysis 11.29.1. By Therapy 11.29.2. By Route of Administration 11.29.3. By End User 11.30. PEST Analysis 11.31. Key Trends 11.31.1. Key Developments 12. Asia Pacific Atopic Dermatitis Drugs Market Analysis 12.1. Asia Pacific Atopic Dermatitis Drugs Market Overview 12.2. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 12.3. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Therapy 12.3.1. Photo Therapy 12.3.2. Directed Therapy 12.4. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 12.5. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.5.1. Injectable 12.5.2. Oral 12.5.3. Topical 12.6. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By End User 12.7. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By End User 12.7.1. Hospitals 12.7.2. Clinics 12.7.3. Research Labs 12.8. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, by Country 12.9. Asia Pacific Atopic Dermatitis Drugs Market Forecast, by Country 12.9.1. China 12.9.2. India 12.9.3. Japan 12.9.4. ASEAN 12.9.5. Rest of Asia Pacific 12.10. Asia Pacific Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 12.11. China Atopic Dermatitis Drugs Market Forecast, By Therapy 12.11.1. Photo Therapy 12.11.2. Directed Therapy 12.12. China Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.12.1. Injectable 12.12.2. Oral 12.12.3. Topical 12.13. China Atopic Dermatitis Drugs Market Forecast, By End User 12.13.1. Hospitals 12.13.2. Clinics 12.13.3. Research Labs 12.14. India Atopic Dermatitis Drugs Market Forecast, By Therapy 12.14.1. Photo Therapy 12.14.2. Directed Therapy 12.15. India Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.15.1. Injectable 12.15.2. Oral 12.15.3. Topical 12.16. India Atopic Dermatitis Drugs Market Forecast, By End User 12.16.1. Hospitals 12.16.2. Clinics 12.16.3. Research Labs 12.17. Japan Atopic Dermatitis Drugs Market Forecast, By Therapy 12.17.1. Photo Therapy 12.17.2. Directed Therapy 12.18. Japan Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.18.1. Injectable 12.18.2. Oral 12.18.3. Topical 12.19. Japan Atopic Dermatitis Drugs Market Forecast, By End User 12.19.1. Hospitals 12.19.2. Clinics 12.19.3. Research Labs 12.20. ASEAN Atopic Dermatitis Drugs Market Forecast, By Therapy 12.20.1. Photo Therapy 12.20.2. Directed Therapy 12.21. ASEAN Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.21.1. Injectable 12.21.2. Oral 12.21.3. Topical 12.22. ASEAN Atopic Dermatitis Drugs Market Forecast, By End User 12.22.1. Hospitals 12.22.2. Clinics 12.22.3. Research Labs 12.23. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Therapy 12.23.1. Photo Therapy 12.23.2. Directed Therapy 12.24. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.24.1. Injectable 12.24.2. Oral 12.24.3. Topical 12.25. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By End User 12.25.1. Hospitals 12.25.2. Clinics 12.25.3. Research Labs 12.26. Asia Pacific Atopic Dermatitis Drugs Market Attractiveness Analysis 12.26.1. By Therapy 12.26.2. By Route of Administration 12.26.3. By End User 12.27. PEST Analysis 12.28. Key Trends 12.28.1. Key Developments 13. Middle East & Africa Atopic Dermatitis Drugs Market Analysis 13.1. Middle East & Africa Atopic Dermatitis Drugs Market Overview 13.2. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 13.3. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.3.1. Photo Therapy 13.3.2. Directed Therapy 13.4. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 13.5. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.5.1. Injectable 13.5.2. Oral 13.5.3. Topical 13.6. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By End User 13.7. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.7.1. Hospitals 13.7.2. Clinics 13.7.3. Research Labs 13.8. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 13.10. GCC Atopic Dermatitis Drugs Market Forecast, By Therapy 13.10.1. Photo Therapy 13.10.2. Directed Therapy 13.11. GCC Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.11.1. Injectable 13.11.2. Oral 13.11.3. Topical 13.12. GCC Atopic Dermatitis Drugs Market Forecast, By End User 13.12.1. Hospitals 13.12.2. Clinics 13.12.3. Research Labs 13.13. Others South Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.13.1. Photo Therapy 13.13.2. Directed Therapy 13.14. South Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.14.1. Injectable 13.14.2. Oral 13.14.3. Topical 13.15. South Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Research Labs 13.16. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.16.1. Photo Therapy 13.16.2. Directed Therapy 13.17. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.17.1. Injectable 13.17.2. Oral 13.17.3. Topical 13.18. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.18.1. Hospitals 13.18.2. Clinics 13.18.3. Research Labs 13.19. Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness Analysis 13.19.1. By Therapy 13.19.2. By Route of Administration 13.19.3. By End User 13.20. PEST Analysis 13.21. Key Trends 13.21.1. Key Developments 14. South America Atopic Dermatitis Drugs Market Analysis 14.1. South America Atopic Dermatitis Drugs Market Overview 14.2. South America Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 14.3. South America Atopic Dermatitis Drugs Market Forecast, By Therapy 14.3.1. Photo Therapy 14.3.2. Directed Therapy 14.4. South America Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 14.5. South America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.5.1. Injectable 14.5.2. Oral 14.5.3. Topical 14.6. South America Atopic Dermatitis Drugs Market Value Share Analysis, By End User 14.7. South America Atopic Dermatitis Drugs Market Forecast, By End User 14.7.1. Hospitals 14.7.2. Clinics 14.7.3. Research Labs 14.8. South America Atopic Dermatitis Drugs Market Value Share Analysis, by Country 14.9. South America Atopic Dermatitis Drugs Market Forecast, by Country 14.9.1. Brazil 14.9.2. Mexico 14.9.3. Rest of South America 14.10. South America Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 14.11. Brazil Atopic Dermatitis Drugs Market Forecast, By Therapy 14.11.1. Photo Therapy 14.11.2. Directed Therapy 14.12. Brazil Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.12.1. Injectable 14.12.2. Oral 14.12.3. Topical 14.13. Brazil Atopic Dermatitis Drugs Market Forecast, By End User 14.13.1. Hospitals 14.13.2. Clinics 14.13.3. Research Labs 14.14. Mexico Atopic Dermatitis Drugs Market Forecast, By Therapy 14.14.1. Photo Therapy 14.14.2. Directed Therapy 14.15. Mexico Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.15.1. Injectable 14.15.2. Oral 14.15.3. Topical 14.16. Mexico Atopic Dermatitis Drugs Market Forecast, By End User 14.16.1. Hospitals 14.16.2. Clinics 14.16.3. Research Labs 14.17. Rest of South America Atopic Dermatitis Drugs Market Forecast, By Therapy 14.17.1. Photo Therapy 14.17.2. Directed Therapy 14.18. Rest of South America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.18.1. Injectable 14.18.2. Oral 14.18.3. Topical 14.19. Rest of South America Atopic Dermatitis Drugs Market Forecast, By End User 14.19.1. Hospitals 14.19.2. Clinics 14.19.3. Research Labs 14.20. South America Atopic Dermatitis Drugs Market Attractiveness Analysis 14.20.1. By Therapy 14.20.2. By Route of Administration 14.20.3. By End User 14.21. PEST Analysis 14.22. Key Trends 14.22.1. Key Developments 15. Company Landscape 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Competitive Benchmarking of Company and Services 15.4. Company Profiles: Key Players 15.4.1. Mylan 15.4.1.1. Company Overview 15.4.1.2. Financial Overview 15.4.1.3. Business Strategy 15.4.1.4. Recent Developments 15.4.1.5. Development Footprint 15.4.2. LEO Pharma 15.4.3. Bayer HealthCare 15.4.4. Encore Dermatology 15.4.5. Novartis AG 15.4.6. Valent Pharmaceutical Inc. 15.4.7. Astellas Pharma Inc. 15.4.8. Meda AB 15.4.9. Bayer Ag 15.4.10. Valeant 15.4.11. Astellas Pharma Inc 15.4.12. Ancor Pharmaceutical 15.4.13.Regenron Pharmaceutical 15.4.14. Allergan 15.4.15.Pfizer Inc 16. Primary Key Insights
  • INQUIRE BEFORE BUYING